Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier

References

• Moinuddin S, Razvi S, Uddin MS, et al. Nasal drug delivery system: a innovative approach. Perce. 2019;15:16.
   Google Scholar
• Laffleur F, Bauer B. Progress in nasal drug delivery systems. Int J Pharmaceut. 2021;607:120994.
   PubMed Web of Science ®Google Scholar
• Chavda VP, Jogi G, Shah N, et al. Advanced particulate carrier-mediated technologies for nasal drug delivery. J Drug Deli Sci Technol. 2022:103569.
   Web of Science ®Google Scholar
• Khatri DK, Preeti K, Tonape S, et al. Nanotechnological advances for nose to brain delivery of therapeutics to improve the Parkinson therapy. Current Neuropharmacology. 2023;21:493–516.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Arzi RS, Sosnik A. Molecular and cellular cues governing nanomaterial–mucosae interactions: from nanomedicine to nanotoxicology. Chem Soci Revi. 2020;49:5058–5100.
   PubMed Web of Science ®Google Scholar
• Johansson ME. Fast renewal of the distal colonic mucus layers by the surface goblet cells as measured by in vivo labeling of mucin glycoproteins. PLOS ONE. 2012;7:e41009.
   PubMed Web of Science ®Google Scholar
• Sonvico F, Clementino A, Buttini F, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharma. 2018;10:34.
   Google Scholar
• Fleischer CC, Payne CK. Nanoparticle–cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res Acco of Chem Rese. 2014;47:2651–2659.
   PubMed Web of Science ®Google Scholar
• Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Bioin. 2007;2:MR17–MR71.
   Google Scholar
• Mygind N, Änggård A. Anatomy and physiology of the nose–pathophysiologic alterations in allergic rhinitis. Clin Rev Allergy. 1984;2:173–188.
   PubMedGoogle Scholar
• Jeong S, Jang J, Lee Y. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. Jo of Phar Inve. 2023;53:119–152.
   PubMed Web of Science ®Google Scholar
• Pathan N, Shende P. Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier. J Control Release. 2021;335:398–407.
   PubMed Web of Science ®Google Scholar
• Suman, JD. Current understanding of nasal morphology and physiology as a drug delivery target. Drug Deliv Transl Res. 2013;3:4–15.
   PubMed Web of Science ®Google Scholar
• Gizurarson S. The effect of cilia and the mucociliary clearance on successful drug delivery. Biol Pharm Bull. 2015;38:497–506.
   PubMed Web of Science ®Google Scholar
• Netsomboon K, Bernkop-Schnürch A. Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm. 2016;98:76–89.
   PubMed Web of Science ®Google Scholar
• Bustos NA, Ribbeck K, Wagner CE. The role of mucosal barriers in disease progression and transmission. Adv Drug Delivery Rev. 2023;200:115008.
   PubMed Web of Science ®Google Scholar
• Leal J, Smyth HD, Ghosh D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharmaceut. 2017;532:555–572.
   PubMed Web of Science ®Google Scholar
• Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363:2233–2247.
   PubMed Web of Science ®Google Scholar
• Tomazic PV, Birner-Gruenberger R, Leitner A, et al. Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis. J Allergy Clin Immunol. 2014;133:741–750.
   PubMed Web of Science ®Google Scholar
• Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc. 2011;8:106–114.
   PubMedGoogle Scholar
• Wagner C, Wheeler K, Ribbeck K. Mucins and their role in shaping the functions of mucus barriers. Annu Rev Cell Dev Biol. 2018;34:189–215.
   PubMed Web of Science ®Google Scholar
• Lieleg O, Ribbeck K. Biological hydrogels as selective diffusion barriers. trends in cell biology. Trends Cell Biol. 2011;21:543–551.
   PubMed Web of Science ®Google Scholar
• Pires PC, Santos AO. Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies. J Control Release. 2018;270:89–100.
   PubMed Web of Science ®Google Scholar
• Kočevar-Nared J, Kristl J, Šmid-Korbar J. Comparative rheological investigation of crude gastric mucin and natural gastric mucus. Biomaterials. 1997;18(9):677–681.
   PubMed Web of Science ®Google Scholar
• Dawson M, Krauland E, Wirtz D, et al. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog. 2004;20:851–857.
   PubMed Web of Science ®Google Scholar
• Formica ML, Real DA, Picchio ML, et al. On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles. Appl Mater Today. 2022;29:101631.
   Web of Science ®Google Scholar
• Shah S, Rangaraj N, Singh SB, et al. Exploring the unexplored avenues of surface charge in nano-medicine. Coll Inter Sci Commun. 2021;42:100406.
   Web of Science ®Google Scholar
• Finbloom JA, Sousa F, Stevens MM, et al. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery. Adv Drug Deli Rev. 2020;167:89–108.
   PubMed Web of Science ®Google Scholar
• Guo Y, Ma Y, Chen X, et al. Mucus penetration of surface-engineered nanoparticles in various pH microenvironments. ACS Nano. 2023;17(3):2813–2828.
   PubMedGoogle Scholar
• Kashyap K, Shukla R. Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges. Curr Drug Deliv. 2019;16:887–901.
   PubMed Web of Science ®Google Scholar
• McGuckin MB, Wang J, Ghanma R, et al. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. J Control Release. 2022;345:334–353.
   PubMed Web of Science ®Google Scholar
• Bala R, Sindhu RK, Kaundle B, et al. The prospective of liquid crystals in nano formulations for drug delivery systems. J Mol Struct. 2021;1245:131117.
   Web of Science ®Google Scholar
• Wu S, Xia Y, Hu Y, et al. Bio-mimic particles for the enhanced vaccinations: lessons learnt from the natural traits and pathogenic invasion. Adv Drug Deli Rev. 2021;176:113871.
   PubMed Web of Science ®Google Scholar
• Kapate N, Clegg JR, Mitragotri S. Non-spherical micro-and nanoparticles for drug delivery: progress over 15 years. Adv Drug Delivery Rev. 2021;177:113807.
   PubMed Web of Science ®Google Scholar
• Lu X, Miao L, Gao W, et al. Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy. Sci Transl Med. 2020;12(556):eaaz6606.
   PubMed Web of Science ®Google Scholar
• Kumar S, Anselmo AC, Banerjee A, et al. Shape and size-dependent immune response to antigen-carrying nanoparticles. J Control Release. 2015;220:141–148.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang Y-Y, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Delivery Rev. 2009;61(2):158–171.
   PubMed Web of Science ®Google Scholar
• Kaliner M, Shelhamer JH, Borson B, et al. Human respiratory mucus. Am Rev Respir Dis. 1986;134:612–621.
   PubMed Web of Science ®Google Scholar
• Bansil R, Turner BS. The biology of mucus: composition, synthesis and organization. Adv Drug Delivery Rev. 2018;124:3–15.
   PubMed Web of Science ®Google Scholar
• Fass D, Thornton DJ. Mucin networks: dynamic structural assemblies controlling mucus function. Curr Opin Struct Biol. 2023;79:102524.
   PubMed Web of Science ®Google Scholar
• McShane A, Bath J, Jaramillo AM, et al. Mucus. Curr Biol. 2021;31:R938–R945.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Sverdlov Arzi R, Sosnik A. Molecular and cellular cues governing nanomaterial-mucosae interactions: from nanomedicine to nanotoxicology. Chem Soc Rev. 2020;49:5058–5100.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Amiji M, Sarmento B. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(4):389–399.
   PubMed Web of Science ®Google Scholar
• Puri V, Sharma A, Kumar P, et al. Thiolation of biopolymers for developing drug delivery systems with enhanced mechanical and mucoadhesive properties: a review. Polymers. 2020;12(8):1803.
   PubMed Web of Science ®Google Scholar
• Sellers LA, Allen A, Morris ER, et al. Mucus glycoprotein gels. Role of glycoprotein polymeric structure and carbohydrate side-chains in gel-formation. Carbohydr Res. 1988;178(1):93–110.
   PubMedGoogle Scholar
• Liu Z, He H. Synthesis and applications of boronate affinity materials: from class selectivity to biomimetic specificity. Acc Chem Res. 2017;50:2185–2193.
   PubMed Web of Science ®Google Scholar
• Shan X, Aspinall S, Kaldybekov DB, et al. Synthesis and evaluation of methacrylated poly (2-ethyl-2-oxazoline) as a mucoadhesive polymer for nasal drug delivery. ACS Appl Polym Mater. 2021;3:5882–5892.
   Web of Science ®Google Scholar
• Porfiryeva NN, Nasibullin SF, Abdullina SG, et al. Acrylated Eudragit® E PO as a novel polymeric excipient with enhanced mucoadhesive properties for application in nasal drug delivery. Int J Pharmaceut. 2019;562:241–248.
   PubMed Web of Science ®Google Scholar
• Wang Y-Y, Lai SK, Suk JS, et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem Int Ed. 2008;47:9726.
   PubMed Web of Science ®Google Scholar
• McCauley HA, Guasch G. Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia. Trends Mol Med. 2015;21(8):492–503.
   PubMed Web of Science ®Google Scholar
• Tomazic PV, Darnhofer B, Birner-Gruenberger R. Nasal mucus proteome and its involvement in allergic rhinitis. Expert Rev Proteomics. 2020;17(3):191–199.
   PubMed Web of Science ®Google Scholar
• Tong J, Gu Q. Expression and clinical significance of mucin gene in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2020;20:1–11.
   PubMed Web of Science ®Google Scholar
• Nur Husna SM, Tan H-T-T, Md Shukri N, et al. Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: overview and pathogenic insights. Front Immunol. 2021;12:663626.
   PubMed Web of Science ®Google Scholar
• Brunner J, Ragupathy S, Borchard G. Target specific tight junction modulators. Adv Drug Delivery Rev. 2021;171:266–288.
   PubMed Web of Science ®Google Scholar
• Chegini Z, Noei M, Hemmati J, et al. The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and staphylococcus aureus in chronic rhinosinusitis. Cell Commun Signaling. 2023;21(1):306.
   PubMed Web of Science ®Google Scholar
• Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022;351:923–940.
   PubMed Web of Science ®Google Scholar
• Li M, Zhao M, Fu Y, et al. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra-and paracellular pathways. J Control Release. 2016;228:9–19.
   PubMed Web of Science ®Google Scholar
• Shim S, Yoo HS. The application of mucoadhesive chitosan nanoparticles in nasal drug delivery. Mar Drugs. 2020;18(12):605.
   PubMed Web of Science ®Google Scholar
• Teng Z, Meng L-Y, Yang J-K, et al. Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity. J Control Release. 2022;351:456–475.
   PubMed Web of Science ®Google Scholar
• Bernocchi B, Carpentier R, Betbeder D. Nasal nanovaccines. Int J Pharmaceut. 2017;530(1–2):128–138.
   PubMed Web of Science ®Google Scholar
• Lim JS, Na HS, Lee HC, et al. Caveolae-mediated entry of salmonella typhimurium in a human M-cell model. Biochem Biophys Res Commun. 2009;390(4):1322–1327.
   PubMed Web of Science ®Google Scholar
• Green BT, Brown DR. Differential effects of clathrin and actin inhibitors on internalization of Escherichia coli and Salmonella choleraesuis in porcine jejunal Peyer’s patches. Vet Microbiol. 2006;113:117–122.
   PubMed Web of Science ®Google Scholar
• Kyd JM, Cripps AW. Functional differences between M cells and enterocytes in sampling luminal antigens. Vaccine. 2008;26(49):6221–6224.
   PubMed Web of Science ®Google Scholar
• Cruz LJ, Rosalia RA, Kleinovink JW, et al. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: a comparative study. J Control Release. 2014;192:209–218.
   PubMed Web of Science ®Google Scholar
• Kumar M, Dogra R, Mandal UK. Nanomaterial-based delivery of vaccine through nasal route: opportunities, challenges, advantages, and limitations. J Drug Delivery Sci Technol. 2022;74:103533.
   Web of Science ®Google Scholar
• Madav Y, Wairkar S. Strategies for enhanced direct nose-to-brain drug delivery. In: Chandrakantsing P, editor. Direct nose-to-brain drug delivery. Amsterdam, Netherlands: Elsevier; 2021. p. 169–184.
   Google Scholar
• Akhter MH, Khalilullah H, Gupta M, et al. Impact of protein corona on the biological identity of nanomedicine: understanding the fate of nanomaterials in the biological milieu. Biomedicines. 2021;9(10):1496.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang W. The Janus of protein corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. J Control Release. 2022;345:832–850.
   PubMed Web of Science ®Google Scholar
• Fasoli E. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine. Biotechnol Appl Biochem. 2021;68:1139–1152.
   PubMed Web of Science ®Google Scholar
• Lombardo R, Musumeci T, Carbone C, et al. Nanotechnologies for intranasal drug delivery: an update of literature. Pharm Dev Technol. 2021;26(8):824–845.
   PubMed Web of Science ®Google Scholar
• Digiacomo L, Pozzi D, Palchetti S, et al. Impact of the protein corona on nanomaterial immune response and targeting ability. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(4):e1615.
   PubMed Web of Science ®Google Scholar
• Wang J, Li Q, Xue J, et al. Shape matters: morphologically biomimetic particles for improved drug delivery. Chem Eng J. 2021;410:127849.
   Web of Science ®Google Scholar
• Bahng JH, Yeom B, Wang Y, et al. Anomalous dispersions of ‘hedgehog’ particles. Nature. 2015;517(7536):596–599.
   PubMed Web of Science ®Google Scholar
• Fung Y-C. Biomechanics: mechanical properties of living tissues. Media: Springer Science & Business; 2013.
   Google Scholar
• Wu L-P, Wang D, Li Z. Grand challenges in nanomedicine. Mater Sci Eng C. 2020;106:110302.
   PubMed Web of Science ®Google Scholar
• Watchorn J, Clasky AJ, Prakash G, et al. Untangling mucosal drug delivery: engineering, designing, and testing nanoparticles to overcome the mucus barrier. ACS Biomater Sci Eng. 2022;8:1396–1426.
   PubMed Web of Science ®Google Scholar
• Marttin E, Schipper NG, Verhoef JC, et al. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Delivery Rev. 1998;29:13–38.
   PubMed Web of Science ®Google Scholar
• Kumar K, Dhawan N, Sharma H, et al. Bioadhesive polymers: novel tool for drug delivery. artificial cells, nanomedicine, and biotechnology. Artific Cells Nanomed Biotechnol. 2014;42(4):274–283.
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Agu RU, Verbeke N, et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Delivery Rev. 2005;57(11):1640–1665.
   PubMed Web of Science ®Google Scholar
• Mackie AR, Goycoolea FM, Menchicchi B, et al. Innovative methods and applications in mucoadhesion research. Macromol biosci. 2017;17:1600534.
   Web of Science ®Google Scholar
• Robinson TE, Moakes RJ, Grover LM. Low acyl gellan as an excipient to improve the sprayability and mucoadhesion of iota carrageenan in a nasal spray to prevent infection with SARS-CoV-2. Front Med Technol. 2021;3:687681.
   PubMedGoogle Scholar
• Freitas AR, Ribeiro AJ, Ribeiro AB, et al. Modification of chicha gum: antibacterial activity, ex vivo mucoadhesion, antioxidant activity and cellular viability. Int j biol macromol. 2023;228:594–603.
   PubMed Web of Science ®Google Scholar
• Alcantara KP, Nalinratana N, Chutiwitoonchai N, et al. Enhanced nasal deposition and anti-coronavirus effect of favipiravir-loaded mucoadhesive chitosan–alginate nanoparticles. Pharmaceutics. 2022;14(12):2680.
   PubMed Web of Science ®Google Scholar
• Vasquez-Martínez N, Guillén D, Moreno-Mendieta SA, et al. In vivo tracing of immunostimulatory raw starch microparticles after mucosal administration. Eur J Pharm Biopharm. 2023;187:96–106. i:
   PubMed Web of Science ®Google Scholar
• Liu S, Yu Q, Guo R, et al. A biodegradable, adhesive, and stretchable hydrogel and potential applications for allergic rhinitis and epistaxis. Adv Healthcare Materials. 2023;12:2302059.
   Google Scholar
• Bakhrushina E, Demina N, Krasnyuk I, et al. Development of the composition of the biopolymer base for nasal gel. Drug Res (Stuttg). 2020;70:97–100.
   PubMed Web of Science ®Google Scholar
• Nimi TN, Manohar DR. An overview on in-situ nasal gel for drug delivery. J Pharmaceutical Sci Res. 2019;11:2585–2589.
   Google Scholar
• Kurakula M, Rao GK. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Delivery Sci Technol. 2020;60:102046.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release. 2020;327:235–265.
   PubMed Web of Science ®Google Scholar
• Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: formulation optimization using factorial design, characterization, and in vitro evaluation. J Pharm Bioallied Sci. 2014;6(4):267.
   PubMedGoogle Scholar
• Nathan KG, Genasan K, Kamarul T. Polyvinyl alcohol-chitosan scaffold for tissue engineering and regenerative medicine application: a review. Mar Drugs. 2023;21(5):304.
   PubMed Web of Science ®Google Scholar
• Ito T, Otani N, Fujii K, et al. Bioadhesive and biodissolvable hydrogels consisting of water‐swellable poly (acrylic acid)/poly (vinylpyrrolidone) complexes. J Biomed Mater Res, Part B. 2020;108:503–512.
   PubMed Web of Science ®Google Scholar
• Selvarajah J, Saim AB, Bt Hj Idrus R, et al. Current and alternative therapies for nasal mucosa injury: a review. Int J Mol Sci. 2020;21(2):480.
   PubMed Web of Science ®Google Scholar
• Giradkar P, Patel DH. Vilazodone hydrochloride multi-dose nasal spray solution for the treatment of depression: design, optimization and evaluation. Curr Drug Ther. 2021;16:224–240.
   Web of Science ®Google Scholar
• Von Zuben EDS, Eloy JO, Inácio MD, et al. Hydroxyethylcellulose-based hydrogels containing liposomes functionalized with cell-penetrating peptides for nasal delivery of insulin in the treatment of diabetes. Pharmaceutics. 2022;14:2492.
   PubMed Web of Science ®Google Scholar
• Trenkel M, Scherließ R. Nasal powder formulations: In-vitro characterisation of the impact of powders on nasal residence time and sensory effects. Pharmaceutics. 2021;13(3):385.
   PubMed Web of Science ®Google Scholar
• Cuggino JC, Blanco ERO, Gugliotta LM, et al. Crossing biological barriers with nanogels to improve drug delivery performance. J Cont Rele. 2019;307:221–246.
   PubMed Web of Science ®Google Scholar
• Pangua C, Reboredo C, Campión R, et al. In Theory and Applications of Nonparenteral Nanomedicines. Amsterdam, Netherlands: Elsevier; 2021; pp. 137–152.
   Google Scholar
• Laffleur F, Hintzen F, Shahnaz G, et al. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Nanomed. 2014;9:387–396.
   PubMed Web of Science ®Google Scholar
• Nazir I, Leichner C, Le-Vinh B, et al. Surface phosphorylation of nanoparticles by hexokinase: A powerful tool for cellular uptake improvement. Jou Col and int Sci. 2018;516:384–391.
   PubMed Web of Science ®Google Scholar
• Abdulkarim M, Laffleur F, Ramos-Pérez V, et al. Novel Zwitterionic Densely-Charged Neutral Sulfobetaine Nanoparticles for Oral Delivery of Therapeutic Peptides.
   Google Scholar
• Shan W, Zhu X, Tao W, et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. . ACS Appd Mat & Int. 2016;8:25444–25453.
   PubMed Web of Science ®Google Scholar
• Yu T, Chan KW, Anonuevo A, et al. Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI). Nanomed: Nanotechn, Bio and Medi. 2015;11:401–405.
   PubMed Web of Science ®Google Scholar
• de Oliveira Junior ER, Santos LCR, Salomão MA, et al. Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating. Drug Deli and Trans Res. 2020;10:1688–1699.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh V, Rahiman N, Cabral H, et al. Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination. Jou of Cont Rele. 2023;362:278–296.
   PubMed Web of Science ®Google Scholar
• Ayoubi‐Joshaghani MH, Seidi K, Azizi M, et al. Potential applications of advanced nano/hydrogels in biomedicine: static, dynamic, multi‐stage, and bioinspired. Adv Funct Mat. 2020;30:2004098.
   Web of Science ®Google Scholar
• Passos M, Dias D, Bastos G, et al. pHEMA hydrogels: Synthesis, kinetics and in vitro tests. Jou Ther Anal and Calori. 2016;125:361–368.
   Web of Science ®Google Scholar
• Huckaby JT, Lai SK. Pegylation for enhancing nanoparticle diffusion in mucus. Adv Drug Delivery Rev. 2018;124:125–139.
   PubMed Web of Science ®Google Scholar
• Xu Q, Ensign LM, Boylan NJ, et al. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano. 2015;9(9):9217–9227.
   PubMed Web of Science ®Google Scholar
• Maisel K, Reddy M, Xu Q, et al. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. Nanomedicine. 2016;11(11):1337–1343.
   PubMed Web of Science ®Google Scholar
• Mašek J, Lubasova D, Lukáč R, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles-important step towards effective mucosal vaccines. J Control Release. 2017;249:183–195.
   PubMed Web of Science ®Google Scholar
• Taipaleenmäki E, Städler B. Recent advancements in using polymers for intestinal mucoadhesion and mucopenetration. Macromol biosci. 2020;20(3):1900342.
   Web of Science ®Google Scholar
• Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81(4):1930–1937.
   PubMed Web of Science ®Google Scholar
• Schattling P, Taipaleenmäki E, Zhang Y, et al. A polymer chemistry point of view on mucoadhesion and mucopenetration. Macro Biosci. 2017;17:1700060.
   Web of Science ®Google Scholar
• Yang D, Liu D, Qin M, et al. Intestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering nanoclustering and strengthening the retrograde pathway. ACS Appl Mater Inter. 2018;10(14):11443–11456.
   PubMed Web of Science ®Google Scholar
• Rohrer J, Partenhauser A, Hauptstein S, et al. Mucus permeating thiolated self-emulsifying drug delivery systems. Euro Jou Pharma Biopharma. 2016;98:90–97.
   PubMed Web of Science ®Google Scholar
• de Sousa IP, Cattoz B, Wilcox MD, et al. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Euro Jou Pharma Biopharma. 2015;97:257–264.
   PubMed Web of Science ®Google Scholar
• Müller C, Leithner K, Hauptstein S, et al. Preparation and characterization of mucus-penetrating papain/poly (acrylic acid) nanoparticles for oral drug delivery applications. Jou Nanopart Res. 2013;15:1–13.
   Web of Science ®Google Scholar
• Khafagy E-S, Morishita M, Kamei N, et al. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharmaceut. 2009;381(1):49–55.
   PubMed Web of Science ®Google Scholar
• Samaridou E, Alonso MJ. Nose-to-brain peptide delivery–the potential of nanotechnology. Bioorg Med Chem. 2018;26(10):2888–2905.
   PubMed Web of Science ®Google Scholar
• Trabulo S, Cardoso AL, Mano M, et al. Cell-penetrating peptides–mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals. 2010;3:961–993.
   Google Scholar
• Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J Biol Chem. 1996;271(30):18188–18193.
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Young PM, Traini D. Strategies to enhance drug absorption via nasal and pulmonary routes. Pharmaceutics. 2019;11(3):113.
   PubMed Web of Science ®Google Scholar
• Na L, Mao S, Wang J, et al. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats. Int J Pharmaceut. 2010;397(1–2):59–66.
   PubMed Web of Science ®Google Scholar
• Saini H, Rapolu Y, Razdan K, et al. Spanlastics: a novel elastic drug delivery system with potential applications via multifarious routes of administration. J Drug Targeting. 2023;31:999–1012.
   PubMed Web of Science ®Google Scholar
• Ansari MD, Saifi Z, Pandit J, et al. Spanlastics a novel nanovesicular carrier: its potential application and emerging trends in therapeutic delivery. AAPS Pharm Sci Tech. 2022;23(4):112.
   PubMed Web of Science ®Google Scholar
• Alharbi WS, Hareeri RH, Bazuhair M, et al. Spanlastics as a potential platform for enhancing the brain delivery of flibanserin: in vitro response-surface optimization and in vivo pharmacokinetics assessment. Pharmaceutics. 2022;14(12):2627.
   PubMed Web of Science ®Google Scholar
• Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–1519.
   PubMed Web of Science ®Google Scholar
• Uchida H, Kondoh M, Hanada T, et al. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide. Biochem Pharmacol. 2010;79(10):1437–1444.
   PubMed Web of Science ®Google Scholar
• Martins PP, Smyth HD, Cui Z. Strategies to facilitate or block nose-to-brain drug delivery. Int J Pharmaceut. 2019;570:118635.
   PubMed Web of Science ®Google Scholar
• Nguyen T-T-L, Duong V-A, Maeng H-J. Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics. 2021;13:1103.
   PubMed Web of Science ®Google Scholar
• Varma MV, Ashokraj Y, Dey CS, et al. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 2003;48:347–359.
   PubMed Web of Science ®Google Scholar
• Le-Vinh B, Le N-MN, Nazir I, et al. Chitosan based micelle with zeta potential changing property for effective mucosal drug delivery. Int j Biol Macromol. 2019;133:647–655.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A. Strategies to overcome the polycation dilemma in drug delivery. Adv Drug Deli Rev. 2018;136:62–72.
   PubMed Web of Science ®Google Scholar
• Oh S, Borrós S. Mucoadhesion vs mucus permeability of thiolated chitosan polymers and their resulting nanoparticles using a quartz crystal microbalance with dissipation (QCM-D). Colloids Surf B Biointerfaces. 2016;147:434–441.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S. DLS and zeta potential–what they are and what they are not? J Control Release. 2016;235:337–351.
   PubMed Web of Science ®Google Scholar
• Di Cola E, Brocca P, Rondelli V, et al. Novel O/W nanoemulsions for nasal administration: structural hints in the selection of performing vehicles with enhanced mucopenetration. Colloids Surf B Biointerfaces. 2019;183:110439.
   PubMed Web of Science ®Google Scholar
• Ways TMM, Filippov SK, Maji S, et al. Mucus-penetrating nanoparticles based on chitosan grafted with various non-ionic polymers: synthesis, structural characterisation and diffusion studies. J Colloid Interface Sci. 2022;626:251–264.
   PubMed Web of Science ®Google Scholar
• Akel H, Csóka I, Ambrus R, et al. In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate nose-to-brain delivery of insulin. Int J Mol Sci. 2021;22(24):13258.
   PubMed Web of Science ®Google Scholar
• Sabir F, Katona G, Ismail R, et al. Development and characterization of n-propyl gallate encapsulated solid lipid nanoparticles-loaded hydrogel for intranasal delivery. Pharmaceuticals. 2021;14(7):696.
   Web of Science ®Google Scholar
• Siddhanta S, Bhattacharjee S, Harrison SM, et al. Shedding light on the trehalose‐enabled mucopermeation of nanoparticles with label‐free raman spectroscopy. Small. 2019;15(33):1901679.
   Web of Science ®Google Scholar
• Yakubov GE, Singleton S, Williamson AM. Methods for assessing mucoadhesion: the experience of an integrative approach. Mucoadhesive Mat Drug Deli Syst. 2014;2014:197–232.
   Google Scholar
• McGlynn JA, Wu N, Schultz KM. Multiple particle tracking microrheological characterization: fundamentals, emerging techniques and applications. J Appl Phys. 2020;127(20):127.
   Web of Science ®Google Scholar
• Schneider CS, Xu Q, Boylan NJ, et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci Adv. 2017;3(4):e1601556.
   PubMed Web of Science ®Google Scholar
• Boyuklieva R, Zagorchev P, Pilicheva B. Computational, in vitro, and in vivo models for nose-to-brain drug delivery studies. Biomedicines. 2023;11(8):2198.
   PubMed Web of Science ®Google Scholar
• Haasbroek‐Pheiffer A, Van Niekerk S, Van der Kooy F, et al. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery. Biopharm Drug Disp. 2023;44:94–112.
   PubMed Web of Science ®Google Scholar
• Volpe DA. Application of method suitability for drug permeability classification. Aaps J. 2010;12(4):670–678.
   PubMed Web of Science ®Google Scholar
• Veronesi MC, Alhamami M, Miedema SB, et al. Imaging of intranasal drug delivery to the brain. Am J Nucl Med Mol Imaging. 2020;10:1.
   PubMed Web of Science ®Google Scholar
• Geva-Zatorsky N, Alvarez D, Hudak JE, et al. In vivo imaging and tracking of host–microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nature Med. 2015;21(9):1091–1100.
   PubMed Web of Science ®Google Scholar
• Hoover EE, Squier JA. Advances in multiphoton microscopy technology. Nat Photonics. 2013;7(2):93–101.
   PubMed Web of Science ®Google Scholar
• Jin C, Ye K, Luan H, et al. Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells. Fitoterapia. 2020;144:104496.
   PubMed Web of Science ®Google Scholar
• Lux CA, Douglas RG, Cho D-Y, et al. Animal models for inflammatory mucosal disease and their potential for studying the microbiome in chronic rhinosinusitis. Rhinology Online. 2019;2(2):69–80.
   Google Scholar
• Emborg ME. Nonhuman primate models of Parkinson’s disease. Ilar J. 2007;48:339–355.
   PubMed Web of Science ®Google Scholar
• Yang M, Lai SK, Wang Y-Y, et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Ed. 2011;50:2597.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Rocha CM, Gonçalves MP, et al. Interactions of microbicide nanoparticles with a simulated vaginal fluid. Mol Pharmaceut. 2012;9:3347–3356.
   PubMed Web of Science ®Google Scholar
• Schömig VJ, Käsdorf BT, Scholz C, et al. An optimized purification process for porcine gastric mucin with preservation of its native functional properties. RSC Adv. 2016;6(50):44932–44943.
   Web of Science ®Google Scholar
• Larhed AW, Artursson P, Gråsjö J, et al. Diffusion of drugs in native and purified gastrointestinal mucus. J Pharmaceut sci. 1997;86(6):660–665.
   PubMed Web of Science ®Google Scholar
• Dimova S, Brewster M, Noppe M, et al. The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro. 2005;19(1):107–122.
   PubMed Web of Science ®Google Scholar
• Wengst A, Reichl S. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. Eur J Pharm Biopharm. 2010;74(2):290–297.
   PubMed Web of Science ®Google Scholar
• Yang X, Chen X, Lei T, et al. The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration. Acta Pharm Sin B. 2020;10(6):1094–1105.
   PubMed Web of Science ®Google Scholar
• Pho T, Champion JA. Surface engineering of protein nanoparticles modulates transport, adsorption, and uptake in mucus. ACS Appl Mater Inter. 2022;14(46):51697–51710.
   PubMedGoogle Scholar
• Yip YL, Lin W, Deng W, et al. Establishment of nasopharyngeal carcinoma cell lines, patient-derived xenografts, and immortalized nasopharyngeal epithelial cell lines for nasopharyngeal carcinoma and epstein–barr virus infection studies. In Anne, WM Lee, editors. Nasopharyngeal carcinoma. Amsterdam, Netherlands: Elsevier; 2019. p. 85–107.
   Google Scholar
• Forbes B, Shah A, Martin GP, et al. The human bronchial epithelial cell line 16HBE14o–as a model system of the airways for studying drug transport. Int J Pharmaceut. 2003;257(1–2):161–167.
   PubMed Web of Science ®Google Scholar
• Tratnjek L, Sibinovska N, Kristan K, et al. In vitro ciliotoxicity and cytotoxicity testing of repeated chronic exposure to topical nasal formulations for safety studies. Pharmaceutics. 2021;13(11):1750.
   PubMed Web of Science ®Google Scholar
• Ramezanpour M, Smith JL, Psaltis AJ, et al. In vitro safety evaluation of a povidone‐iodine solution applied to human nasal epithelial cells. Int Forum of Alle Rhino. 2020;10:1141–1148.
   PubMed Web of Science ®Google Scholar
• Sousa F, Castro P. Cell-based in vitro models for nasal permeability studies. In: Bruno S, Catarina LP, José DN, editors. Concepts and models for drug permeability studies. Amsterdam, Netherlands: Elsevier; 2016. p. 83–100.
   Google Scholar
• Mercier C, Jacqueroux E, He Z, et al. Pharmacological characterization of the 3D MucilAir™ nasal model. Eur J Pharm Biopharm. 2019;139:186–196.
   PubMed Web of Science ®Google Scholar
• Schlachet I, Sosnik A. Mixed mucoadhesive amphiphilic polymeric nanoparticles cross a model of nasal septum epithelium in vitro. ACS Appl Mater Inter. 2019;11(24):21360–21371.
   PubMed Web of Science ®Google Scholar
• Ye D, Dawson KA, Lynch I. A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers. Analyst. 2015;140(1):83–97.
   PubMed Web of Science ®Google Scholar
• Noi I, Schlachet I, Kumarasamy M, et al. Permeability of novel chitosan-g-poly (methyl methacrylate) amphiphilic nanoparticles in a model of small intestine in vitro. Polymers. 2018;10(5):478.
   PubMed Web of Science ®Google Scholar
• Na K, Lee M, Shin H-W, et al. In vitro nasal mucosa gland-like structure formation on a chip. Lab Chip. 2017;17:1578–1584.
   PubMed Web of Science ®Google Scholar
• Usman Khan M, Cai X, Shen Z, et al. Challenges in the development and application of organ-on-chips for intranasal drug delivery studies. Pharmaceutics. 2023;15(5):1557.
   PubMed Web of Science ®Google Scholar
• Bendas S, Koch EV, Nehlsen K, et al. The path from nasal tissue to nasal mucosa on chip: part 1–establishing a nasal in vitro model for drug delivery testing based on a novel cell line. Pharmaceutics. 2023;15(9):2245.
   PubMed Web of Science ®Google Scholar
• Williams G, Suman JD. In vitro anatomical models for nasal drug delivery. Pharmaceutics. 2022;14(7):1353.
   PubMed Web of Science ®Google Scholar
• Alfaifi A, Hosseini S, Esmaeili AR, et al. Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults. Int J Pharmaceut. 2022;622:121858.
   PubMed Web of Science ®Google Scholar
• Deruyver L, Rigaut C, Lambert P, et al. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Delivery Rev. 2021;175:113826.
   PubMed Web of Science ®Google Scholar
• Berben P, Bauer-Brandl A, Brandl M, et al. Drug permeability profiling using cell-free permeation tools: overview and applications. Eur J Pharmaceut Sci. 2018;119:219–233.
   PubMed Web of Science ®Google Scholar
• Furubayashi T, Inoue D, Nishiyama N, et al. Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats. Pharmaceutics. 2020;12(1):79.
   PubMed Web of Science ®Google Scholar
• Fransén N, Espefält Westin U, Nyström C, et al. The in vitro transport of dihydroergotamine across porcine nasal respiratory and olfactory mucosa and the effect of a novel powder formulation. J Drug Delivery Sci Technol. 2007;17(4):267–271.
   Web of Science ®Google Scholar
• Bartos C, Szabó-Révész P, Horváth T, et al. Comparison of modern in vitro permeability methods with the aim of investigation nasal dosage forms. Pharmaceutics. 2021;13(6):846.
   PubMed Web of Science ®Google Scholar
• Haasbroek-Pheiffer A, Viljoen A, Steenekamp J, et al. An ex vivo investigation on drug permeability of sheep nasal epithelial tissue membranes from the respiratory and olfactory regions. Curr Drug Deliv. 2024;21:115–125.
   PubMed Web of Science ®Google Scholar
• Teng Z, Yang J, Chen X, et al. Intranasal morphology transformation nanomedicines for long-term intervention of allergic rhinitis. ACS Nano. 2023;17(24):25322–25334.
   PubMed Web of Science ®Google Scholar
• Li M, Pan G, Yang Y, et al. Smart aligned multi-layered conductive cryogels with hemostasis and breathability for coagulopathy epistaxis, nasal mucosal repair and bleeding monitoring. Nano Today. 2023;48:101720.
   Web of Science ®Google Scholar
• Utomo E, Domínguez-Robles J, Moreno-Castellanos N, et al. Development of intranasal implantable devices for schizophrenia treatment. Int J Pharmaceut. 2022;624:122061.
   PubMed Web of Science ®Google Scholar
• Gao X, Xiong Y, Chen H, et al. Mucus adhesion vs. mucus penetration? Screening nanomaterials for nasal inhalation by MD simulation. JControl Release. 2023;353:366–379.
   PubMed Web of Science ®Google Scholar
• Du J, Shao X, Bouteiller J-MC, et al. Computational optimization of delivery parameters to guide the development of targeted nasal spray. Sci Rep. 2023;13:4099.
   PubMed Web of Science ®Google Scholar
• Borthakur MP, Succi S, Sterpone F, et al. In-silico analysis of airflow dynamics and particle transport within a human nasal cavity. J Comput Sci. 2021;54:101411.
   Web of Science ®Google Scholar
• Feng Y, Zhao J, Hayati H, et al. Tutorial: understanding the transport, deposition, and translocation of particles in human respiratory systems using computational fluid-particle dynamics and physiologically based toxicokinetic models. J Aerosol Sci. 2021;151:105672.
   Web of Science ®Google Scholar
• Saltzman J, Bendtsen C. Modeling the effect of mucin binding in the gut on drug delivery. Bull Math Biol. 2019;81:3460–3476.
   PubMed Web of Science ®Google Scholar
• Faizal W, Ghazali NNN, Khor C, et al. Computational fluid dynamics modelling of human upper airway: a review. Comput Methods Programs Biomed. 2020;196:105627.
   PubMed Web of Science ®Google Scholar
• Funk J, Hall G, Crandall J, et al. Linear and quasi-linear viscoelastic characterization of ankle ligaments. J Biomech Eng. 2000;122(1):15–22.
   PubMed Web of Science ®Google Scholar
• Sedaghat MH, George UZ, Abouali O. A nonlinear viscoelastic model of mucociliary clearance. Rheol Acta. 2021;60(6–7):371–384.
   Web of Science ®Google Scholar
• Roy Y, Sivathanu V, Das SK. Effect of bunching of cilia and their interplay on muco-ciliary transport. Comput Biol Med. 2013;43(11):1758–1772.
   PubMed Web of Science ®Google Scholar
• Giesekus H. A simple constitutive equation for polymer fluids based on the concept of deformation-dependent tensorial mobility. J Non-Newtonian Fluid Mech. 1982;11(1–2):69–109.
   Web of Science ®Google Scholar
• Xu L, Jiang Y. Mathematical modeling of mucociliary clearance: a mini-review. Cells. 2019;8(7):736.
   PubMed Web of Science ®Google Scholar
• Vachhani S, Kleinstreuer C. Comparison of micron-and nano-particle transport in the human nasal cavity with a focus on the olfactory region. Comput Biol Med. 2021;128:104103.
   PubMed Web of Science ®Google Scholar
• Inthavong K, Das P, Singh N, et al. In silico approaches to respiratory nasal flows: A review. J Biomech. 2019;97:109434.
   PubMed Web of Science ®Google Scholar
• Zhao L, Arias SL, Brito IL, et al. Coarse-grained modeling and experimental investigation of the viscoelasticity of human gut mucus and nanoparticle dynamics. bioRxiv. 2023; 2002;2028:530485.
   Google Scholar
• Wang J, Shi X. Molecular dynamics simulation of diffusion of nanoparticles in mucus. Acta Mech Solida Sinica. 2017;30(3):241–247.
   Web of Science ®Google Scholar
• Salo-Ahen OM, Alanko I, Bhadane R, et al. Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes. 2020;9:71.
   Web of Science ®Google Scholar
• Porfiryeva NN, Semina II, Salakhov IA, et al. Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery. Nanomedicine. 2021;37:102432.
   PubMed Web of Science ®Google Scholar